Atrial fibrillation: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 15: | Line 15: | ||
|} | |} | ||
{{Atrial fibrillation}} | {{Atrial fibrillation}} | ||
{{Patient}} | |||
{{CMG}} | {{CMG}} | ||
{{SK}} AF; afib | {{SK}} AF; afib; lone fibrillator | ||
==[[Atrial fibrillation overview|Overview]]== | ==[[Atrial fibrillation overview|Overview]]== | ||
| Line 46: | Line 45: | ||
==[[Atrial fibrillation overview of treatment|Treatment]]== | ==[[Atrial fibrillation overview of treatment|Treatment]]== | ||
Cardioversion | ===Cardioversion=== | ||
[[Atrial fibrillation cardioversion|Overview]] | [[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]] | [[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]] | |||
===Anticoagulation=== | |||
[[Atrial fibrillation anticoagulation|Overview]] | [[Warfarin]] | [[Dabigatran#Converting from or to Warfarin|Converting from or to Warfarin]] | [[Dabigatran#Converting from or to Parenteral Anticoagulants|Converting from or to Parenteral Anticoagulants]] | [[Dabigatran]] | |||
===Dabigatran=== | |||
[[dabigatran#Dosing|Dosing]] | [[Dabigatran#Surgery and Interventions|Discontinuation for Surgery and Interventions]] | [[Dabigatran#WARNINGS AND PRECAUTIONS| Warnings and Precautions]] | [[Dabigatran#Adverse Reactions|Adverse Reactions]] | [[Dabigatran#Use in Specific Populations|Use in Specific Populations Such as Pregnancy]] | [[Dabigatran#Overdosage|Overdosage]] | [[Clinical Pharmacology of Dabigatran|Clinical Pharmacology]] | [[FDA Review of Data From the RE-LY Trial on September 20th, 2010|FDA Review of the RE-LY Data]] | [[A comparison of the RE-LY and Rocket AF Trials ]] | [[Estimates of Cost Per Year of Life Saved for Dabigatran]] | |||
Rate and Rhythm Control | ===Rate and Rhythm Control=== | ||
[[Atrial fibrillation rate control|Rate Control]] | [[Atrial fibrillation maintenance of rate control and sinus rhythm|Maintenance of Sinus Rhythm]] | |||
Surgery | ===Surgery=== | ||
[[Atrial fibrillation invasive treatment#Radiofrequency ablation|Radiofrequency Ablation]] | [[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]] | |||
[[Atrial fibrillation secondary prevention|Secondary Prevention]] | ===[[Atrial fibrillation secondary prevention|Secondary Prevention]]=== | ||
[[Atrial fibrillation supportive trial data|Supportive Trial Data]] | ===[[Atrial fibrillation supportive trial data|Supportive Trial Data]]=== | ||
==Case Studies== | ==Case Studies== | ||
| Line 69: | Line 74: | ||
{{Electrocardiography}} | {{Electrocardiography}} | ||
{{Circulatory system pathology}} | {{Circulatory system pathology}} | ||
[[Category:Arrhythmia]] | |||
[[Category:Cardiology]] | |||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date Cardiology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
Revision as of 05:15, 2 September 2013
 |
Resident Survival Guide |
 |
Sinus rhythm  |
Atrial fibrillation  |
|
Atrial Fibrillation Microchapters | |
|
Special Groups | |
|---|---|
|
Diagnosis | |
|
Treatment | |
|
Cardioversion | |
|
Anticoagulation | |
|
Surgery | |
|
Case Studies | |
|
Atrial fibrillation On the Web | |
For patient information, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: AF; afib; lone fibrillator
Overview
Classification
Pathophysiology
Causes
Differentiating Atrial Fibrillation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Special Groups
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hypertrophic Cardiomyopathy | Hyperthyroidism | Pulmonary Diseases | Pregnancy
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Afib with LBBB EKG Examples | Chest X Ray | Echocardiography | Holter Monitoring and Exercise Stress Testing | Cardiac MRI
Treatment
Cardioversion
Overview | Electrical Cardioversion | Pharmacological Cardioversion
Anticoagulation
Overview | Warfarin | Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants | Dabigatran
Dabigatran
Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Rate and Rhythm Control
Rate Control | Maintenance of Sinus Rhythm
Surgery
Radiofrequency Ablation | Maze Open Heart Surgery
Secondary Prevention
Supportive Trial Data
Case Studies
Related Chapters
- Atrial flutter
- Ashman phenomenon
- The AF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines